Target Screening

The choice of the right epitope to be recognized by TCRs is critical for reducing off-target toxicities. Bioinformatic tools like  Expitope enables the examination of the expression of newly identified epitopes in healthy tissue, especially in vital organs like the heart and brain, to avoid unspecific binding of TCRs leading to fatal damage to healthy tissue.

Target Screening Publications

Dolores J. Schendel. Front. Oncol. 2023, Volume 13 - 2023 |
Anja Mösch, Silke Raffegerst, Manon Weis, Dolores J. Schendel and Dmitrij Frishman. Frontiers in Genetics Review published: 19 November 2019 doi: 10.3389/fgene.2019.01141
Jaravine, V., Raffegerst, S., Schendel, DJ., Frishman, D. Bioinformatics 2017 Jan 1;33(1):104-111. doi: 10.1093/bioinformatics/btw567.
Haase, K., Raffegerst, S., Schendel, D., Frishman, D. Bioinformatics. 2015 Jun 1;31(11):1854-6. doi: 10.1093/bioinformatics/btv068.
Becker, C., Pohla, H., Frankenberger, B., Schüler, T., Assenmacher, M., Schendel, D.J. and Blankenstein, T. 2001. Nat Med.; 7 (10):1159–1162.

Target Screening Abstracts


Expitope 3.0 An Advanced in silico Webtool Empowered with Machine Learning for Enhanced pHLA Epitope Prediction and Safety Assessment Simone Thomas, Martin Sebastian Karg, Andrea Coluccio, Barbara Lösch, Dolores J Schendel, Dmitrij Frishman



TCR-based Therapies for Solid Tumors

Case Study Spotlight: Introducing Innovations at Each Step of TCR-T Therapy Development; Dolores Schendel


CAR-TCR Summit

Combined Molecular & Cellular Tools are Required to Assess Safety of TCR-T Immunotherapies; Tristan Holland


CIMT – Cancer Immunotherapy Annual Meeting 2013, Mainz

Wehner C., Ellinger C., Raffegerst S., Wilde S., Mosetter B., Schendel D.J., Milošević S., 2013. Isolation of antigen-specific CD8+ T lymphocytes and molecular characterization of antigenic epitopes. CIMT Mainz, Germany.

Download PDF